Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
Dongyu Duan,1,* Aiping Wang,1,* Ling Ni,2 Liping Zhang,1 Xiuju Yan,1 Ying Jiang,1 Hongjie Mu,1 Zimei Wu,1 Kaoxiang Sun,1 Youxin Li1,2 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Phar...
Main Authors: | Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-03-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/trastuzumab--and-fabprime-fragment-modified-curcumin-peg-plga-nanopart-peer-reviewed-article-IJN |
Similar Items
-
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
by: Eurydice Angeli, et al.
Published: (2024-04-01) -
Dispatching for order-driven FABs with backward pegging
by: Yong H. Chung, et al.
Published: (2016-12-01) -
Bacterial Enoyl-Reductases: The Ever-Growing List of Fabs, Their Mechanisms and Inhibition
by: Fernanda S. M. Hopf, et al.
Published: (2022-06-01) -
Production in Bacteria and Characterization of Engineered Humanized Fab Fragment against the Nodal Protein
by: Jwala P. Sivaccumar, et al.
Published: (2023-08-01) -
Exploration of the blocking effect of Fab fragment of IgG autoantibody on erythrocyte autoantigens
by: Haitao HUANG, et al.
Published: (2024-09-01)